Transdermal Rivastigmine: Management of Cutaneous Adverse Events and Review of the Literature

Author： Greenspoon Jill   Herrmann Nathan   Adam David N.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.7, 2011-07, pp. : 575-583

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivastigmine Transdermal Patch: A Review of its Use in the Management of Dementia of the Alzheimer's Type

By Dhillon Sohita  

Drugs, Vol. 71, Iss. 9, 2011-06 ,pp. : 1209-1231

Adis International

Access to resources Recommend Favorite

Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis

By Wen Warren  

Expert Opinion on Drug Safety, Vol. 12, Iss. 3, 2013-05 ,pp. : 309-319

Informa Healthcare

Access to resources Recommend Favorite

Periocular Cutaneous Malignancies: A Review of the Literature

By Slutsky Jordan B.   Jones Evan C.  

Dermatologic Surgery, Vol. 38, Iss. 4, 2012-04 ,pp. : 552-569

Elsevier

Access to resources Recommend Favorite

Intravascular Brachytherapy: Indications and Management of Adverse Events

By Balram Bhargava  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 6, 2004-01 ,pp. : 385-394

Adis International

Access to resources Recommend Favorite

Lipid Management Strategies for the Prevention of Adverse Cardiovascular Events

By  

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 159-161

Karger

Access to resources Recommend Favorite